New Zealand markets closed

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.21000.0000 (0.00%)
At close: 02:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.20B
Enterprise value 9.85B
Trailing P/E 8.51
Forward P/E 6.69
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)0.12
Price/book (mrq)0.46
Enterprise value/revenue 0.04
Enterprise value/EBITDA 1.14

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-37.63%
S&P500 52-week change 323.10%
52-week high 32.0750
52-week low 31.2100
50-day moving average 31.4148
200-day moving average 31.4905

Share statistics

Avg vol (3-month) 31.06k
Avg vol (10-day) 32k
Shares outstanding 5919.07M
Implied shares outstanding 66.78B
Float 81.65B
% held by insiders 124.01%
% held by institutions 124.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.08
Forward annual dividend yield 46.99%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 333.88%
5-year average dividend yield 4N/A
Payout ratio 458.80%
Dividend date 321 Aug 2017
Ex-dividend date 418 Jul 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.43%
Operating margin (ttm)3.39%

Management effectiveness

Return on assets (ttm)2.42%
Return on equity (ttm)6.27%

Income statement

Revenue (ttm)264.22B
Revenue per share (ttm)71.53
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 9.51B
Net income avi to common (ttm)3.79B
Diluted EPS (ttm)0.1400
Quarterly earnings growth (yoy)1.60%

Balance sheet

Total cash (mrq)37.18B
Total cash per share (mrq)10.04
Total debt (mrq)55.3B
Total debt/equity (mrq)67.36%
Current ratio (mrq)1.34
Book value per share (mrq)18.92

Cash flow statement

Operating cash flow (ttm)2.38B
Levered free cash flow (ttm)-3.5B